Nxstage Medical Inc
(NXTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 59,009 | 56,951 | 57,021 | 55,903 | 53,768 |
| Cost of Goods | 36,620 | 35,639 | 35,851 | 36,363 | 34,903 |
| Gross Profit | 22,389 | 21,312 | 21,170 | 19,540 | 18,865 |
| Operating Expenses | 26,300 | 25,610 | 25,193 | 23,614 | 23,752 |
| Operating Income | -3,291 | -3,659 | -3,172 | -3,711 | -3,984 |
| Interest Expense | 1,456 | 1,193 | 1,201 | 1,186 | 1,170 |
| Other Income | -79 | -52 | 54 | -146 | -170 |
| Pre-tax Income | -4,826 | -4,904 | -4,319 | -5,043 | -5,324 |
| Income Tax | 237 | 240 | 245 | 235 | 226 |
| Net Income Continuous | -5,063 | -5,144 | -4,564 | -5,278 | -5,550 |
| Net Income | $-5,063 | $-5,144 | $-4,564 | $-5,278 | $-5,550 |
| EPS Basic Total Ops | -0.09 | -0.09 | -0.08 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.09 | -0.09 | -0.08 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.09 | -0.09 | -0.08 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.09 | -0.09 | -0.08 | -0.10 | -0.10 |
| EBITDA(a) | $2,569 | $2,061 | $2,500 | $2,245 | $1,785 |